Neisseria Meningitides Meningitis

Infectious Diseases
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Vaccine
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Walvax Biotechnology
Walvax BiotechnologyChina - Kunming
1 program
1
Yuxi Walvax MPV ACYW® vaccinePhase 4Vaccine1 trial
Active Trials
NCT04450498CompletedEst. Jul 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Walvax BiotechnologyYuxi Walvax MPV ACYW® vaccine

Clinical Trials (1)

NCT04450498Walvax BiotechnologyYuxi Walvax MPV ACYW® vaccine

A Study to Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Start: Dec 2020Est. completion: Jul 2021
Phase 4Completed

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space